p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Top Cited Papers
- 8 April 2007
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 9 (5), 573-580
- https://doi.org/10.1038/ncb1571
Abstract
Tp53 is the most commonly mutated tumour-suppressor gene in human cancers. In addition to the loss of tumour-suppression function, some missense mutants gain novel oncogenic activities. To elucidate the nature of the gain of function, we introduced the most common p53 cancer mutations (R248W and R273H) independently into the humanized p53 knock-in (HUPKI) allele in mice. Tumour-suppressor functions of p53 are abolished in p53-mutant mice. Several lines of evidence further indicate gain-of-function of p53 mutants in promoting tumorigenesis. p53(R248W) mice rapidly succumb to certain types of cancers not commonly observed in p53(-/-) mice. Interchromosomal translocations, a type of genetic instability rarely observed in p53(-/-) cells, are readily detectable in p53-mutant pre-tumor thymocytes. Although normal in p53(-/-) mouse cells, the G(2)-M checkpoint is impaired in p53-mutant cells after DNA damage. These acquired oncogenic properties of mutant p53 could be explained by the findings that these p53 mutants interact with the nuclease Mre11 and suppress the binding of the Mre11-Rad50-NBS1 (MRN) complex to DNA double-stranded breaks (DSBs), leading to impaired Ataxia-telangiectasia mutated (ATM) activation. Therefore, p53 gain-of-function mutants promote tumorigenesis by a novel mechanism involving active disruption of critical DNA damage-response pathways.Keywords
This publication has 28 references indexed in Scilit:
- Ser46 Phosphorylation Regulates p53-Dependent Apoptosis and Replicative SenescenceCell Cycle, 2006
- A New Role of p53 in Maintaining Genetic Stability in Embryonic Stem CellsCell Cycle, 2005
- p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expressionNature, 2004
- Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni SyndromeCell, 2004
- Histone H2AX: A Dosage-Dependent Suppressor of Oncogenic Translocations and TumorsCell, 2003
- The Thousand Doors that Lead to Death: p53-Dependent Repression and ApoptosisCancer Biology & Therapy, 2003
- ATM and related protein kinases: safeguarding genome integrityNature Reviews Cancer, 2003
- Targeted disruption of NBS1 reveals its roles in mouse development and DNA repairThe EMBO Journal, 2002
- Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research toolOncogene, 2001
- p53 Mutations in Human CancersScience, 1991